The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday endorsed Novavax’s more conventional COVID-19 vaccine for use as a primary shot for eligible Americans aged 18 and older.
The CDC’s independent advisory committee voted unanimously to recommend the vaccine for adults after reviewing safety and effectiveness data at a public meeting on Tuesday.
Signing off on the Novavax jab gives Americans the option of choosing a shot with a more familiar type of vaccine technology that has been used for more than 30 years in the United States, the CDC said in a statement.
Figures from the CDC show that around 78 percent of eligible Americans have received at least one dose of a COVID-19 vaccine, while a significant number remain unvaccinated and distrusting of the jabs….